Literature DB >> 1557995

Hemorrhagic colitis associated with Escherichia coli O157:H7.

M B Cohen1, R A Giannella.   

Abstract

E. coli O157:H7, the predominant serotype of EHEC, is a cause of both outbreaks and sporadic cases of hemorrhagic colitis. In sporadic cases, and especially in outbreaks, there is an association with the consumption of improperly cooked ground beef. Both young children and geriatric patients have an increased attack rate for EHEC infection as well as an increased incidence of the two sequelae of intestinal infection with EHEC, hemolyticuremic syndrome, and thrombotic thrombocytopenic purpura. The hallmark of hemorrhagic colitis due to EHEC is the development of bloody diarrhea several days after the onset of nonbloody diarrhea and abdominal pain. Fever is usually absent or low-grade. The pathogenesis of EHEC infection is probably related to at least two bacterial virulence factors: adherence of bacteria to intestinal mucosa and production of one or more cytotoxins. These cytotoxins are closely related to Shiga toxin and therefore are often referred to as Shiga-like toxins. Treatment for hemorrhagic colitis is supportive care; most illnesses are self-limited. At present, there is no evidence that antimicrobial therapy shortens the course of illness or prevents the development of sequelae.

Entities:  

Mesh:

Year:  1992        PMID: 1557995

Source DB:  PubMed          Journal:  Adv Intern Med        ISSN: 0065-2822


  9 in total

1.  Polyethylene glycol diminishes pathological effects of Citrobacter rodentium infection by blocking bacterial attachment to the colonic epithelia.

Authors:  Wentao Qi; Suhasini Joshi; Christopher R Weber; Ramesh K Wali; Hemant K Roy; Suzana D Savkovic
Journal:  Gut Microbes       Date:  2011-09-01

2.  Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli.

Authors:  K Ramotar; E Henderson; R Szumski; T J Louie
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

3.  Hfq negatively regulates type III secretion in EHEC and several other pathogens.

Authors:  Elizabeth A Shakhnovich; Brigid M Davis; Matthew K Waldor
Journal:  Mol Microbiol       Date:  2009-08-24       Impact factor: 3.501

4.  Transport proteins promoting Escherichia coli pathogenesis.

Authors:  Fengyi Tang; Milton H Saier
Journal:  Microb Pathog       Date:  2014-04-18       Impact factor: 3.738

5.  Aluminum based reflective nanolens arrays to improve the effectiveness of ultraviolet inactivation of Escherichia coli O157:H7 and Listeria monocytogenes in water and a sucrose solution.

Authors:  Junsoo Park; Changhoon Chai
Journal:  Food Sci Biotechnol       Date:  2020-05-13       Impact factor: 2.391

6.  Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases.

Authors:  Ahmet Koluman; Nejat Akar; İbrahim C Haznedaroğlu
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

7.  Analysis of individual patient data to describe the incubation period distribution of Shiga-toxin producing Escherichia coli.

Authors:  A Awofisayo-Okuyelu; I Hall; E Arnold; L Byrne; N McCarthy
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

Review 8.  Escherichia coli type III secretion system 2: a new kind of T3SS?

Authors:  Mingxu Zhou; Zhiyan Guo; Qiangde Duan; Philip R Hardwidge; Guoqiang Zhu
Journal:  Vet Res       Date:  2014-03-19       Impact factor: 3.683

Review 9.  Infectious gastroenterocolitides in children: an update on emerging pathogens.

Authors:  P M Sherman; M Petric; M B Cohen
Journal:  Pediatr Clin North Am       Date:  1996-04       Impact factor: 3.278

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.